Retractable Technologies, Inc. filings document the regulatory record for a Texas medical device manufacturer whose common stock trades on NYSE American under RVP. Recent Form 8-K reports cover material events such as operating-results releases, workforce reductions, product designation announcements, and dividends on Series II and Series III Class B Convertible Preferred Stock.
The company’s proxy materials disclose annual meeting matters, director elections, board structure, shareholder voting procedures, and executive-governance information. Together, the filings describe Retractable’s public-company capital structure, recurring event disclosures, governance processes, and formal exhibits tied to its safety medical products business.
Retractable Technologies (RVP) reported an insider purchase by Mr. Shaw, its President and CEO, Director, and 10% Owner. On 10/23/2025, he bought 356 shares of common stock at a weighted average price of $0.951, made pursuant to a Rule 10b5-1(c) trading plan adopted on August 22, 2024.
Following the transaction, Mr. Shaw beneficially owns 15,733,385 shares directly and 831,600 shares indirectly. The indirect holdings include 500,000 shares over which he has investment power as trustee for a family member, and he has voting control over the remainder pursuant to a voting agreement.
Retractable Technologies (RVP) reported an insider purchase by its President, CEO, Director, and 10% owner, Mr. Shaw. On 10/22/2025, he acquired 10,000 shares of common stock at a weighted average price of $0.96 (Form 4, code P).
Following the transaction, he beneficially owns 15,733,029 shares directly and 831,600 shares indirectly. As noted, he has investment power over 500,000 shares as trustee for a family member and voting control over the remainder pursuant to a voting agreement. A Rule 10b5-1 plan was noted with an adoption date of August 22, 2024.
Retractable Technologies (RVP): Mr. Shaw (Director, President and CEO, and 10% Owner) reported a purchase of 14,204 shares of common stock on 10/14/2025 at a weighted average price of $0.9256 (transaction code P).
Following the transaction, he beneficially owns 15,723,029 shares directly and 831,600 shares indirectly. The indirect holdings include 500,000 shares over which he has investment power as Trustee for a family member and the remainder subject to a voting agreement. A Rule 10b5-1 plan was adopted on August 22, 2024.
Retractable Technologies, Inc. reporting person Thomas J. Shaw (President, CEO, Director and >10% owner) acquired 30,000 shares of common stock on 10/08/2025 at a weighted average price of $0.9233. After the purchase Mr. Shaw beneficially owns 15,708,825 shares directly and has an indirect beneficial interest in 831,600 shares as Trustee for a family member; voting control over the remainder is held via a voting agreement. The transaction was executed under a Rule 10b5-1 trading plan adopted on Aug 22, 2024. The Form 4 was signed by an attorney-in-fact on 10/09/2025.
Retractable Technologies, Inc. filed a Form 8-K to report that it has declared a dividend for holders of its Series II and Series III Class B Convertible Preferred Stock. The company disclosed this action through a press release that is attached as Exhibit 99 to the report, ensuring these preferred shareholders are informed about the new dividend.
The filing is limited to announcing this dividend declaration and does not include common stock dividend details, financial results, or other operational updates.
Thomas J. Shaw, President and CEO of Retractable Technologies, acquired 5,000 shares of the company's common stock on 09/29/2025 at a weighted average price of $0.8201 under a Rule 10b5-1 plan adopted 08/22/2024. After the transaction, Mr. Shaw directly beneficially owns 15,678,825 shares and indirectly holds 831,600 shares for which he has voting or investment control as Trustee for a family member. The filing was signed by an attorney-in-fact on 09/30/2025.
Thomas J. Shaw, President & CEO, director and 10% owner of Retractable Technologies, reported a purchase of 17,500 shares of the company on 09/24/2025 at a weighted-average price of $0.802 under a Rule 10b5-1 plan adopted on 08/22/2024. After the transaction he beneficially owns 15,673,825 shares directly and 831,600 shares indirectly.
The filing notes Mr. Shaw holds investment power over 500,000 shares as trustee for a family member and retains voting control over the remaining indirectly held shares pursuant to a voting agreement. The Form 4 was signed by an attorney-in-fact on 09/25/2025.
Thomas J. Shaw, President, CEO and >10% owner of Retractable Technologies, Inc. (RVP), reported an insider purchase under a Rule 10b5-1 plan. On 09/23/2025 Mr. Shaw purchased 2,500 shares of RVP common stock at a weighted-average price of $0.815 per share. After the transaction he directly beneficially owned 15,656,325 shares and indirectly owned 831,600 shares (the indirect holdings include >500,000 shares held in trust for a family member where he has investment power and voting control over the remainder via a voting agreement). The Form 4 was signed by an attorney-in-fact on 09/24/2025 and notes the 10b5-1 plan adoption date of August 22, 2024.
Retractable Technologies reported an insider acquisition by its President and CEO, Thomas J. Shaw. Under a Rule 10b5-1 plan adopted August 22, 2024, 3,000 shares of common stock were purchased on 09/03/2025 at a weighted-average price of $0.782 per share. After the transaction Mr. Shaw beneficially owns 15,653,825 shares directly and has indirect investment power over 831,600 shares as trustee for a family member; he retains voting control over the remaining indirectly held shares via a voting agreement. The Form 4 was signed by an attorney-in-fact on 09/04/2025.
Thomas J. Shaw, President, CEO and a director of Retractable Technologies, Inc. (RVP), reported an insider purchase of company common stock under a Rule 10b5-1 plan. On 09/02/2025 Mr. Shaw acquired 5,500 shares at a weighted-average price of $0.803 per share, increasing his direct beneficial ownership to 15,650,825 shares. He also holds 831,600 shares indirectly, including investment power over 500,000 shares as trustee for a family member and voting control over the remainder via a voting agreement. The 10b5-1 plan was adopted on August 22, 2024.